T cell memory is a hallmark of adaptive immunity. Two broad subsets, effector memory (TEM) and central memory (TCM) have been defined largely by their migratory capacities1. CD62Llo CCR7lo TEM circulate through peripheral tissues, while CD62Lhi CCR7hi TCM home to secondary lymphoid tissues1,2. More recently, another distinct subset, tissue-resident memory T cells (TRM) have been described. TRM have been found in several tissues, including the skin, gut, lung and brain3,4,5,6. Once established, TRM are maintained independently of circulating TEM and TCM and their presence correlates with superior protection against local viral challenge3,5,7. However, the exact role of TRM vs. recruited circulating memory T cells in controlling viral replication is unclear. Furthermore, due to the confined patrolling area of TRM, the capacity of TRM to mediate protection against infection at distal sites is unknown.

A recent paper by Xiaodong Jiang et al.8 investigated these issues in a skin infection model using adoptively transferred TCR transgenic CD8 T cells that recognize the ovalbumin protein (OT-I) and vaccinia virus expressing ovalbumin (VACV). They first characterized the requirements necessary for establishment of TRM in the skin, and found that unlike other epithelial tissues such as the female genital tract9, entry of CD8 T cells into the skin was independent of CD4 T cells and IFNγ. However, T cell expression of ligands for E- and P-selectin, two adhesion molecules that are expressed constitutively and are upregulated on inflamed endothelial cells of skin blood vessels, was necessary for seeding of the skin with OT-I T cells. These data parallel the requirement for circulating TEM CD4 T cell entry into inflamed skin10. Furthermore, in agreement with previous studies using a different virus, herpes simplex virus type 1 (HSV-1)10, the authors found that after VACV infection, while CD8 T cells were retained within the skin, CD4 T cells were not.

The differential expression of homing molecules such as CD62L and CCR7 on subsets of memory T cells indicates their preferential migration to lymphoid or non-lymphoid tissues during homeostasis. However, studies using parabiotic mice have shown that memory T cells that reside in peripheral tissues such as the brain and gut do not participate in homeostatic circulation; rather, they appear to be maintained independently of circulating memory T cells7. By surgically joining VACV-immunized mice with unimmunized partners, the authors found that TCM populations in tissues such as the spleen and lymph node equilibrated between the parabionts, while TRM populations in the skin did not. This indicated that like the brain and gut, skin TRM populations were excluded from the pool of circulating memory T cells. Additionally, this parabiosis study indicates that like the gut, the skin must be seeded relatively early in the T cell response in order to establish a TRM population11. Jiang et al. also note that TRM populations, while fully capable of effector function like their TEM and TCM counterparts, can be further distinguished by their differential expression of surface molecules, such as the lack of markers CD127 and CD122, and high expression of CD69 and CD103.

Other viral infection models such as HSV-1 have suggested that local memory CD8 T cells can be directly activated in peripheral tissues12 and participate in controlling viral replication3. However, it has been difficult to separate the relative contributions of recruited vs. resident memory T cells in mediating protection. To address this issue, Jiang et al. separated immunized and unimmunized parabiotic pairs once the TCM compartment had equilibrated and gave the mice a skin challenge with VACV. The challenged mice were then treated with FTY720, an S1P1 modulator that sequesters lymphocytes in secondary lymphoid organs, thus preventing the recruitment of circulating T cells to the site of infection13. They discovered that TRM were superior to TCM in controlling a secondary infection, as the immunized parabiont controlled viral replication significantly better than the unimmunized partner. Furthermore, they found no difference in the viral titers of the untreated and FTY720-treated immunized parabionts. This suggests that in the VACV infection model, TRM are sufficient to mediate protection against reinfection, even in the absence of any input from circulating T cells.

When a host is immunized through the skin by methods such as scarification, previous studies have implied that the TRM will remain local and patrol an area of tissue that is directly adjacent to the site of infection. For example, in the HSV-1 infection model, it has been shown that when mice are infected on one flank, that flank is better protected against subsequent challenge than the contralateral, unimmunized flank3. Migration of T cells into tissues such as the skin and gut requires the expression of particular homing markers that are most strongly upregulated when T cells are activated via immunization routes that involve the target tissue14. Ligands to some of the skin homing markers upregulated by activated T cells are constitutively expressed in blood vessel endothelium, albeit at a lower level than inflamed tissue. This raises questions as to whether T cells activated through local skin infection can accumulate in distal unimmunized skin, and whether these T cells can provide preferential protection compared to T cells activated through other immunization routes. To address these questions, Jiang et al. immunized mice on one ear using VACV and then examined the accumulation of T cells in the other ear. They found that activated OT-I cells were capable of migrating to the uninfected ear, and that the number of cells found in the uninfected ear could be boosted by immunizing mice multiple times through various skin routes. Furthermore, when mice were challenged in the previously uninfected ear, viral titers were significantly lower in mice immunized via skin scarification compared to mice immunized intraperitoneally (Figure 1). Together with the T cell number data, the authors suggest that TRM in the skin can be established at sites distal to the initial infection, and that these TRM may play a role in providing widespread protection against reinfection.

Figure 1
figure 1

Skin epidermal infection by virus leads to TRM residency and local or global antiviral protection. When the host is infected via skin scarification, the resulting inflammation increases expression of chemoattractants and adhesion molecules such as P- and E-selectin on the endothelium of the blood vessels. T cells activated through this route upregulate skin homing markers such as P- and E-selectin ligands. Collectively, these events lead to the recruitment of circulating, antigen-specific effector/effector memory (TEM) CD8 T cells into the infected tissue. The recruited CD8 T cells establish a pool of resident memory T cells (TRM) that can provide protection against future skin infections. Jiang et al. show that upon multiple skin immunizations, circulating effector/TEM CD8 T cells also accumulate at uninfected sites. These CD8 T cells can then form a TRM population that is immunologically protective. However, the establishment of TRM in uninfected skin is dependent on the route of immunization, as skin-independent methods such as intraperitoneal injection did not lead to protection against a secondary skin challenge.

In summary, the study by Jiang and colleagues show that TRM established in the skin are maintained independently of circulating TCM. Furthermore, they demonstrate that TRM alone are sufficient to protect against pathogens such as vaccinia virus, although the role that different subsets of memory T cells play in mediating immunity will likely vary depending on the infectious agent10,15. Importantly, Jiang et al. show that through prime-boosting, a substantial TRM population can be established at distal skin sites absent of infection or inflammation. This suggests that the frontline defense that TRM can provide in barrier tissues does not have to be limited by the location of immunization (Figure 1). In future studies, it will be important to continue to gain an understanding of TRM, including the factors that lead to their establishment and maintenance. Despite the variety of tissues in which TRM have been described, TRM appear to share certain phenotypic and functional characteristics, such as the expression of surface markers CD103 and CD69, as well as the ability to produce effector molecules such as IFNγ and granzyme B5,6,8,16. Thus, it will be interesting to determine whether there is a common pathway by which TRM differentiate, or whether each tissue has its own individual requirements. Beyond establishment, the mechanism that mediates the long-term survival of TRM is unknown. Previous studies have shown that TRM from tissues such as the brain do not survive well when taken out of their tissue of residence6. This suggests that the signals that sustain TRM may be locally provided and may even be tissue specific, different from the cytokines that maintain systemic TCM and TEM. Understanding how TRM are established and the roles that they play in protecting against invading pathogens will be critical in designing vaccines and immunotherapies that target specific tissues.